The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...

Under the theme 'Imaging the Individual', RSNA 2025 challenged the radiology community to push into new frontiers and close ...

The new excipient system, called Curablend Vet, is designed to work with CurifyLabs’ automated Compounding System Solution (CSS), an automated platform that prints the medications. Together, Curablend ...

The biochips market is poised for robust growth driven by technological advancements and increased healthcare needs. Opportunities abound in diagnostics, drug discovery, and personalized medicine, ...

Visual intelligence and collaborative AI approaches may advance health care, according to a keynote speaker at AIMed25.“Our recent work focuses on making AI for health care more accurate, efficient ...

When you’re next at the movies, if there’s a particularly gnarly scene where a character gets hurt, take a quick glance at ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...

We’ve been talking about this for years now. Personalized medicine. Or precision medicine, if you prefer that term. The idea is simple enough on paper-stop treating patients like averages and start ...

As healthcare leaders face the growing demand for patient-centered care (PCC), the juggling act of improving patient satisfaction, controlling costs, and driving innovation can be overwhelming.

WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence. Informed by 29 studies and 15,000+ patient profiles; ...